BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
See today's BioWorld
Home
» AI firm Exscientia draws Roche to partnering table, adds $26M in series B
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
AI firm Exscientia draws Roche to partnering table, adds $26M in series B
Jan. 8, 2019
By
Nuala Moran
No Comments
LONDON – It was double delight for Exscientia Ltd., as the artificial intelligence (AI) specialist sealed a CHF67 million (US$68.3 million) drug discovery deal with Roche Holding AG and announced the closing of a $26 million series B round.
BioWorld